ERIKA CHAMPION: Open Payments
NPI 1881456036 · CROFTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 78 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $850 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $242 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $147 |
| Phathom Pharmaceuticals, Inc. | 24 | $139 |
| GlaxoSmithKline, LLC. | 6 | $107 |
| Astellas Pharma US Inc | 2 | $74 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Lilly USA, LLC | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| PFIZER INC. | 1 | $18 |
Products named: CAPLYTA, VOQUEZNA, VRAYLAR, UBRELVY, TRELEGY ELLIPTA, Veozah, Auvelity, QULIPTA.
Industry payments across KY — which companies pay providers there.
